Liver cirrhosis study looks at cholesterol marker levels
NCT ID NCT04199910
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study measures levels of a substance called 4beta-hydroxycholesterol in the blood of people with liver cirrhosis. It compares these levels to those in people with pneumonia, Crohn's disease, or ulcerative colitis. The goal is to understand how cirrhosis and certain medications affect this marker. About 120 participants are being recruited from a hospital in Finland.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oulu University Hospital
Oulu, 90029 OYS, Finland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New study tracks blood sugar in liver disease patients on common drug
- New drug aims to stop liver failure in NASH patients
- Can spleen surgery save kidneys in liver patients?
- Spleen surgery may change fat levels in liver patients – study to watch